1. Home
  2. ALBT vs IMCC Comparison

ALBT vs IMCC Comparison

Compare ALBT & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALBT
  • IMCC
  • Stock Information
  • Founded
  • ALBT 2014
  • IMCC 1980
  • Country
  • ALBT United States
  • IMCC Israel
  • Employees
  • ALBT N/A
  • IMCC N/A
  • Industry
  • ALBT Biotechnology: Biological Products (No Diagnostic Substances)
  • IMCC Medicinal Chemicals and Botanical Products
  • Sector
  • ALBT Health Care
  • IMCC Health Care
  • Exchange
  • ALBT Nasdaq
  • IMCC Nasdaq
  • Market Cap
  • ALBT 9.5M
  • IMCC 8.0M
  • IPO Year
  • ALBT N/A
  • IMCC N/A
  • Fundamental
  • Price
  • ALBT $0.42
  • IMCC $2.25
  • Analyst Decision
  • ALBT
  • IMCC
  • Analyst Count
  • ALBT 0
  • IMCC 0
  • Target Price
  • ALBT N/A
  • IMCC N/A
  • AVG Volume (30 Days)
  • ALBT 84.1K
  • IMCC 28.1K
  • Earning Date
  • ALBT 08-12-2024
  • IMCC 08-12-2024
  • Dividend Yield
  • ALBT N/A
  • IMCC N/A
  • EPS Growth
  • ALBT N/A
  • IMCC N/A
  • EPS
  • ALBT N/A
  • IMCC N/A
  • Revenue
  • ALBT $959,516.00
  • IMCC $53,886,735.00
  • Revenue This Year
  • ALBT N/A
  • IMCC $11.51
  • Revenue Next Year
  • ALBT N/A
  • IMCC $19.17
  • P/E Ratio
  • ALBT N/A
  • IMCC N/A
  • Revenue Growth
  • ALBT 6.08
  • IMCC 12.87
  • 52 Week Low
  • ALBT $0.24
  • IMCC $1.13
  • 52 Week High
  • ALBT $1.70
  • IMCC $8.10
  • Technical
  • Relative Strength Index (RSI)
  • ALBT 44.94
  • IMCC 39.76
  • Support Level
  • ALBT $0.45
  • IMCC $1.80
  • Resistance Level
  • ALBT $0.49
  • IMCC $2.98
  • Average True Range (ATR)
  • ALBT 0.05
  • IMCC 0.32
  • MACD
  • ALBT -0.01
  • IMCC 0.02
  • Stochastic Oscillator
  • ALBT 8.04
  • IMCC 38.17

About ALBT Avalon GloboCare Corp.

Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. It focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.

About IMCC IM Cannabis Corp.

IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.

Share on Social Networks: